Home/Filings/4/0001209191-21-039373
4//SEC Filing

Nisen Perry 4

Accession 0001209191-21-039373

CIK 0000818686other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 7:45 AM ET

Size

7.4 KB

Accession

0001209191-21-039373

Insider Transaction Report

Form 4
Period: 2021-06-09
Nisen Perry
Director
Transactions
  • Exercise/Conversion

    Restricted Share Units

    2021-06-0912,6680 total
    Ordinary Shares (12,668 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2021-06-09+12,66844,286 total
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on June 9, 2020 and vested on June 9, 2021.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001683791

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:45 AM ET
Size
7.4 KB